Derek Bickerstaff
Chairman at ONE HEALTH GROUP PLC
Replay available
Preliminary results for the year ended 31 March 2026 hosted by One Health Group (LSE:OHGR) on Investor Meet Company, held 2026-07-06.

On 6ix: 6ix.com/event/one-health-group-plc-ohgr-preliminary-results-for-the-year-ended-31-march-2026
Automated transcript · Written by software from the replay's audio. It can mishear names and figures; the replay is the record.
0:01 Good morning, and welcome to the ONE HEALTH GROUP PLC investor presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged and could be submitted at any time via the q and a tab situated on the right hand corner of your screen. Simply type in your questions and press send. The company may not be in a position to answer every question it receives during the meeting itself. However, the company can review all questions submitted today and publish responses where it's appropriate to do so. Before we begin, I'd like to submit the following poll. I'd now like to hand you over to the management team. Derek, good morning, sir. Hi. Good morning. Hi. Well, welcome everyone, and thank you for attending for our twenty twenty six full year results. My name's Derek Bickerstaff. I'm the founder and chairman of ONE HEALTH. I'm an orthopedic surgeon by trade, and so I have about forty years of experience in the health service. Adam? Yep. My name is Adam Bins. I'm the chief executive ONE HEALTH GROUP. Do my formal introduction in a minute, but, we'll start the presentation.
0:59 Okay. So what is ONE HEALTH? Well, ONE HEALTH is an organization that provides medical services to the NHS. Specifically, we provide medical services in the form of elective surgery covering orthopedics, spinal surgery, gynecology, and general surgery. And these four specialties constitute about eighty percent of those people waiting on the waiting list for surgery, excluding ophthalmology. We provide this service through a contract which we first obtained in 2012 called any qualified provider. And that allows us to accept referrals directly from the general practitioner. And so this is extremely important for ONE HEALTH because this allows us to get to own the complete pathway. So we don't subcontract to trust hospitals or any anyone else.
1:49 We own the patient from first referral through to final discharge. And we provide our services in a novel way different to any other independent sector provider because we've got moved we've moved from a hospital centric model to a community centric model, which is one of the three pillars of the ten year health plan. So we send we see our patients in a in a around 40 plus community clinics where our subspecialist surgeons leave the hospital, see the patients locally. If they need surgery, then we contract with a present 14 independent sector hospitals and they have their operation within there. The patient is then back out into the community where they see our consulted surgeons again for the rehabilitation and eventual discharge.
2:37 So we will demonstrate to you how we've been growing organically, certainly since COVID, but even from before COVID. So we constantly increase our footprint where we see patients. However, what we have noticed is that there are certain areas where our patients have to travel too far for surgery because there's poor NHS provision and there's no independent sector provision. And these companies tend to be there's high demand for NHS care, but they tend to be more underprivileged and certainly under resourced areas. So in those areas, we're going to build our surgical hubs and we will build the network of surgical hubs which will further enhance our revenue, and profits. And we'll explain what a surgical hub is and our plans on on how we're going to operate then. The first surgical hub is actually in construction already, but we'll discuss this later.
3:26 Okay. So in terms of how a patient arrives at ONE HEALTH, there's something called patient choice, which is established in 2009 under Blair's government. And in theory, what this means is when a patient visits their GP and needs a secondary consultation, they're given a range of choices of of of providers' secondary care. Very similar to a Google search. So the the GP has a system called ERS, electronic referral system. So when you put in what you need to be seen for and where you are, ONE HEALTH will always feature quite highly on that search, if you like, in terms of where we are, predominantly because we operate all our first point of contact with patients in outreach clinics, of which there were 40 at the end of the year 40 at the end of the year. And that's the first time a patient will see a ONE HEALTH consult consultant, and they will appear on the GP's search system called ERS. We're also very quick and provide consultations in very quick time, and we obviously got a very good reputation.
4:15 So patients choose ONE HEALTH GROUP at the GP surgery for their provider of secondary care. It's really important to note there's no cost to the patient. We are paid by the NHS, we provide our care free to that patient. This works through a system called the NHS tariff. So in very simple terms, every single thing we do from a consultation to physiotherapy to a procedure has a price on this tariff, like a big price list. And we then pay the consultant per item of service as well. So clearly, it's attractive to them as well in terms of attracting consultants to the group. Just in terms of the waiting list, there's been lots of focus in the press since the pandemic on the the number of people waiting for procedures with NHS. It's around seven point one million at the end of March. So the patient choice agenda upon which we receive patients isn't really touching that waiting list. All the patient at ONE HEALTH has seen over the past five years, bar a few, has been brand new patients. Bypassing the waiting list can be straight to ONE HEALTH GROUP. But longer term, clearly, there has been a need to get that waiting list down, and that's really where we'll see a significant amount of growth beyond the organic growth we'll demonstrate today, but certainly, the initial point of source of a patient is through a GP referral through patient choice.
5:26 On the right hand side of that slide, you can see on the screen there, we're showing you how we allocate the this is inpatient activity, so a procedure, a typical hip replacement of which we were we will get paid £7,500. Today, we pay a good amount of that in the event hospitals that we used. We book capacity in the event hospitals across England. We then pay the consultants and the nieces directly. We pay for diagnostics and physio, and the balance left is our 20% gross margin as seen in 2026. That independent hospital charges is the bulk of the cost today, and that will change slightly where we open surgical hubs, whereby we'll internalize some of that margin, which we'll demonstrate. So this is a depiction of the pathway that, ONE HEALTH runs. As I as I mentioned, we own the patient from referral right the way through to discharge.
6:11 So referral, patients are referred to, into us, from the GP, usually through a system called ERS, which is e referral system. And it's basically like a Google search. So in the GP surgery or independently at home, the patient can log on to this and then they will look to see where the nearest provider is for for for what they're looking for, such as a hip replacement or or a knee replacement. And because ONE HEALTH runs lots of community clinics, we will inevitably be be quite close to where they live. They'll then look at the waiting times and again, we're able to offer waiting times which are far shorter than the NHS. So for those two reasons, that's the the the real reason why patients choose us. We also get patients referred to us by trust hospitals who are trying to manage their own internal waiting list. And if they're struggling, we provide access to our pathway, and and so they will refer patients to us. So fundamentally, the patients come in at the referral area, and that's the point at which they're picked up by our, patient liaison team.
7:15 They then perform a logistical task whereby they match the patient with the subspecialty problem with the surgeon with the subspecialty interest into a clinic near to the patient. The patient then is then seen in the clinic near to their home by our subspecialist surgeon. And the surgeon arrives there with we we were in an electronic patient record, so on the laptop or desktop, the patient will have access to all the patient records and all the patient's diagnostics such as x rays and scans, etcetera. So the surgeon sees the patient there. The patient might need further investigations, which again we organize out in the community. But then the patient will will then the surgeon will come to a decision as to how to manage the patient. Sixty percent of our referrals don't need surgery and so they would be referred back to the GP with advice on further further conservative management.
8:07 The forty percent that do need surgery, our patient liaison team again, match that surgeon with the subspecialty interest of the patient in a operating facility near to their home, and we were in four we we work from 14 independent sector operating facilities at present. The patient then gets discharged and the patient is again seen by the same subspecialty surgeon and also undergoes all their rehabilitation. So our patient liaison team perform a logistical task matching the patient throughout the whole of the pathway. And you won't be surprised to learn that we're already investigating various AI models that can help increase our proficiency and productivity throughout this whole whole pathway. So why do people choose ONE Health? Well, first two, I I I've already mentioned.
8:57 It's very we're to offer the NHS short waiting times and we offer clinics local to the patient so they don't have to travel. With regards to continuity of care, the patients are seen by the same subspecialty surgeon through every step of their management. In an NHS hospital, they might be seen by a resident doctor, by a nurse specialist, by a staff grade specialist, as well as the consultant. So so so we offer a complete continuity of care. The inpatient facilities we use are all in independent independent sector hospitals, and that is valued by our patients. There's plenty of parking. They like the the setup of the hospital, the private rooms, etcetera. I've mentioned our patient liaison team, and an additional factor I didn't mention is that patients are given a named person when they first book onto that care pathway.
9:49 So throughout the pathway, if there's any problems, they can contact that patient in the patient liaison that that, work in the patient liaison team who will be able to manage that problem for them. So it's like providing a private practice service, but this is all for NHS patients. So when we measure our quality of care and we use, the measurements that, the NHS wants us to to, which is called friends and family, We have this huge, hugely high number of ninety nine point five percent of patients would recommend or likely or extremely likely, to recommend further surgery, further treatment with us. So this is a huge, number. And in comparison to the NHS, they, they report figures of around about twenty five percent.
10:35 So clearly, the pathway that we offer is valued by our patients. Okay. So review update on the business with a bit more details to follow in terms of our our numbers, our position. So this is really a story of five years perpetual growth. Very pleased to announce that's continued as of this morning, released our results. So revenue of 31,600,000, a growth of 11%, 50 of double digit growth. EBITDA particularly strong at 2.6 versus 2,000,000 last year, a growth of 28 as you can see. An important measure on that slide is the cash position. So admittedly, £11,100,000 a year end includes the IPO raised last March. But over that same period, we spent 2,800,000 on a combination of surgical development, dividends, and developing our head office, and we still got 11,100,000 left after eleven point four last year, which demonstrates how much cash we generate organically just through ongoing activity.
11:26 I think an important message in terms of longevity of contracts, over 80% of our work of the £30,000,000 roughly is now contracts or long term contracts. Historically, we used to renew every contract every year. So we started a conversation over two years ago now to get longer contracts, which is well received. So the perception that everything's on a rolling twelve months at risk of loss is not really the reality. All our contracts are now longer term, and we've never lost a contract. We usually keep on growing contract activity, predominantly by opening new areas and doing noncontract activity, getting on radar, and then formalizing that through a longer term agreement. So we see a perpetual organic growth. I'm gonna explain how that's gonna work before we move to strategic growth. And there's a there's a slight coming on into the geography and where we are, but in very loose terms, we took 70% of England's ICBs last year, which is a significant number of the of the total opportunity. In addition to work with local trusts, of which the six work was in the previous year, gave us more work again this year, and we'll explain what that means shortly.
12:24 That resulted in increase in surgical procedures, obviously, and obviously new patient consultations up at the top. More subtle points on that slide, but in terms of the contract, the shareholder base ONE HEALTH GROUP, we have 22 of our subcontracted consultants, of which they're now just over 80, their own shares in ONE HEALTH GROUP. They bought in the Aquis IPO back in November 22 and have all held shares since and made it from both dividends and capital growth over that time. So in terms of detail, within the business, we have a number of operational and financial KPIs, which we we track. So the first one, there's operational KPIs, as we've talked about already, new patients, consultations, and surgical procedures, all growing significantly over the past five years. No drop backs.
13:09 Consultants, key to growth, which Derek will touch on shortly, but 88 at the end of twenty twenty six, and that continues to grow. And indeed, there are more onboarded since March and into this new financial year. Our reach leads the same story. 40 end of the year. There are more now than there were at the end of the year. So constant constant continually growing that geographic footprint through the development of outreach facilities and then inpatient facilities in private hospitals primarily. And, again, the final bit on that slide, the trusts we've supported, and this is the real waiting list activity, the 7,100,000 at end of March. We see some of that through trust transfers, traditionally end of the year, but the important message is that 95% of our work over the last twelve months has been from GP referrals. Those patients have totally bypassed the waiting list coming to ONE HEALTH GROUP by choosing ONE HEALTH GROUP PLATION CHOICE. There's still a huge opportunity within the 7,100,000 people waiting the end of March.
14:02 In terms of headline financials, again, the story of growth. The only one that's slightly down is cash, which I explained already. Growth despite spend of over 2,800,000 on dividends and hub investment. But, again, strong growth in EBITDA to nearly 2,600,000. Earnings per share up as you'd expect. Dips per share continue that journey. We've always paid dividends both pre and post listing. No plans to change that. And to put it in perspective, people say, why do you pay dividends when you're trying to grow a hip hub network? Dividend cost to the business this year is about 800,000. Hubs cost between 8 and 9,000,000, so it's a small price to pay. But, obviously, we've got people invest for dividends as well as capital growth, so we look to maintain that. And in terms of the headline EBITDA, we talk about adjusted EBITDA to adjust for the cost of listing on AIM in 2025. So up by that £400,000 year ending March 25, we've grown by nearly 600,000 or 28% between '25 and '26.
14:56 I'm very pleased to keep confirming growth past five years perpetual. So what are our three drivers for growth? These we look upon we look at constantly. Have we got enough patients? Have we got enough surgeons to operate on these patients? Have we got enough operating capacity to do the operations? So patient demand. As Adam said, there are still 7,100,000 patients on the waiting list, which is a huge number. It has decreased recently, but nonetheless, seven point one million is a huge number. The government's goal is to bring the waiting list down to ninety two percent of patients waiting not more than eighteen weeks, and that equates to around about three to 4,000,000 people on the waiting list. So we've got about 4,000,000 people that need to come off the waiting list over the next three years, which is a huge task.
15:47 The NHS has been, not reliant upon, but the NHS has looked to the independent sector to help in this over the last twenty five or thirty years. And at present, the NHS provides about 11% of that cover. So there are a vast amount of patients out there. As we said, most of our patients come from patient choice, but we also get referrals from six local trust hospitals. So so we don't consider there being a shortage of patients. We have a full order book if you like for patients. Do we have enough surgeons? Well, again, we're good at we're good at attracting surgeons. We we contracted with another, eight, clinicians over the last year. So we don't have difficulty. We often find patients apply to join us, but we're very strict on who we bring on board. We have a very strict onboarding process and the surgeons have to fit into the ethos, the vision of what ONE Health is providing with its community based model.
16:43 The reason surgeons like us is we generally work in more underprivileged areas. So you won't really find a ONE HEALTH clinic in say, WILMSLLOW or Virginia Waters where there's a huge amount of private practice. We tend to operate in areas where there's low private practice. So there isn't enough private medical insurance or self pay work for the surgeons. Clearly, surgeons could be paid paid more per case, then they would take that. But in the areas we work, they don't have that option. So they like ONE HEALTH because we provide them with full clinics and full operating theatres. The other reason that surgeons like us is we have a very, very robust clinical management system where we measure clinical audit system, where we measure everything that the surgeons do. So we're able to tell them what their complication rates are, etcetera, etcetera. And this is very important because over a lifetime as a surgeon, mistakes will be made and claims may be made against that surgeon. And because we have all the data, we're able to support the surgeon with any investigations that may occur. And the surgeons like that. It's like a comfort blanket around them rather than working in isolation in a in a private hospital.
17:53 The other reason the surgeons like us is that we pay per a fixed fee per item. So every consultation, every operation attracts a fee so they know exactly what they're going to get. So we don't have any problem finding surgeons. With regards to operating capacity, again, we're we're good at finding new hospitals. We've increased the number of hospitals we work in this year and there's another three or four hospitals that we know are gonna come on in the next year. So we're constantly growing the numbers independent sector facilities that we use for our operations. But also, when we're when we work with an independent sector partner, we increase the number of operations that we do with with them year on year. So we're very good at doing more surgeries in the hospitals we have and also finding more hospitals.
18:40 However, what we have noticed is that there are certain areas and these tend to be in more under resourced resourced areas where there's high NHS demand and they tend to be more underprivileged areas where the NHS isn't providing a good service and the independent sector won't open a hospital there because it can't attract any self pay or private medical insurance. So we're finding that we're having to transfer patients too far for their operations. So our intention is to build surgical hubs in these areas. We will we will explain this later, but we've already started our first surgical hub, and we plan to open a network of surgical hubs operating in these under resourced high demand, but more underprivileged areas. Okay. So let's talk about our operating footprint today, and this is very much about where we are pre surgical hubs, but I'll explain that in more detail.
19:29 So the dark blue area on the right hand side is where we are today, and that's our operating footprint across a couple of ICBs. But where we grow, we grow in the periphery of the orange section, which should be in the next three years, and the yellow is in the next five years. And it's a very simple hub and spoke model. We open outreach clinics on the periphery of where we are today, which lets us tech lets us test demand for NHS patients. If they're successful, we widen that capacity. If they're not, we find a different one. So it's a very easy, flexible way to test growth. Should we start getting very very full clinics, we then find another independent hospital within that footprint to then take the patient in for surgery should that be required. And just a reminder, only forty percent of all new patients require surgery, so it's not not all the patients we speak to or have consultations with. So, again, we target regions with a heavy reliance on NHS, not enough cash to self bill or have private medical insurance, but more importantly, where there are regions where there's insufficient supply, be that independent hospitals or NHS facilities, we'll build a surgical hub.
20:26 So in terms of the x's on the map, the light blue one is an existing site I'll come on to explain more detail about. The green x's are other location identified that meet the criteria for the development of surgical hubs. So I'll talk about the light blue one first. Okay. So what sorry. What do we mean by a surgical hub? Well, what we don't mean is a hospital. We don't need a hospital because all our consultations, our diagnostics, our rehabilitation are done out in the community. So a surgical hub for us is very simple. It's an operating theater, a recovery area, and sufficient beds around that to be able to maintain the throughput we wish to. Surgical hubs are not a new concept. They've been around for decades. When I first started ONE HEALTH twenty two years ago, I did a tour of physician owned ambulatory centers in America, which effectively surgical hubs. Surgical hubs are used throughout Europe.
21:20 The government is supporting this. They want us to own surgical hubs. They are trying to open surgical hubs within the NHS, but they haven't really got the capital to be able to do true completely geographically distant surgical hubs. So they are looking towards the to the independent sector to help with this. And the concept of surgical support, hubs is fully supported by the Royal College of Surgeons. So we're pushing against an open door, regarding this. Now the type of cases that we'll do these surgical in these surgical hubs are the high demand work, hip replacements, knee replacements, and, spinal surgery. We don't need a surgical hub to do mainly mainly the the rest of the work we do is day case surgery. We've got plenty of other capacity to be able to do that. And the advantage of the surgical hub, primarily the advantage to the patient is they get their operations in a in a center near to their home. But for us as an organization, profitability.
22:16 So we intend to open a network of surgical hubs, and we'll explain later how we're doing that. Okay. So hub number one. This is very much in construction. You can see the photo bottom right hand side there. That was taken this weekend and shows very much something coming out of the ground now, which is really great news. So in terms of what the surgical hub is in ONE HEALTH world, it's a single operating theater and 12 bedrooms. Now the logic behind that is that the sort of stuff we'll do, hip replacements, knee replacements, and spinal surgery, ninety nine percent of those patients will need one night stays. So although the initial modeling to generate 6,000,000 better revenue is based on only four patients a day, to give you some very round numbers, there's physical capacity built in to get up to six patients a day, and therefore, six overnight beds, 16 patients following day, health health hence, 12 bedrooms.
23:05 Again, it's not a hospital. Again, if you look at the geographic footprint there on the on the top, the first bullet point, it only covers a site of 1.8 acres, of which naught point four acres is the home itself. So very small, very compact, very efficient, only used for doing surgeries. And because of that, it's relatively cheap to run. Only 20 staff covering twenty four hours. So a fairly small workforce, single level, and fairly low capital cost into this development. This site will be complete early, full year '28 in readiness for bringing in patients from the area. And in terms of where this is in North Lincolnshire at Scumthorpe, we have a fairly significant ONE HEALTH demand in that area, and all patients requiring surgery travel back towards Sheffield. So this is absolutely the sweet spot of high demand where patients traveling too far for surgery.
23:50 And one of the benefits of the ONE HEALTH model, because of the nature of our receiving patient g r from ERS referrals of GPs, we can drive our own demand. We can have more capacity when the hope's nearing completion to ensure we've got a full order book when we're ready to go. So we can effectively start prebooking patients into the hub when it's complete months in advance. And in terms of targeting for key individuals, we recruited our surgical hub manager a couple of weeks ago, now working within the business, doing some really good work. And once we get close to opening, we'll be to to recruiting staff to the local area, tapping into our network. Bearing in mind, the the existing model of taking a consultant and the subcontractor to the hospital will be the same at the outset. So all we're looking for is hospital and ward staff. So make some really good progress on that front. Moving on from that, we've got two more sites identified.
24:37 I was out there last week looking in both South Derbyshire and West Yorkshire. Two other good sites identified, and we'll start the process quite soon to acquire land at one of those two sites. And in terms of lessons learned on the first one, we'll be starting planning very, very early in the process to ensure there's no delays around a step by step approach. We've got a model. That model you can see top right hand side will effectively a copy and paste blueprint. We'll drop into the footprint, get planning, and start as soon as we can, but we'll acquire the land first. So we're confident with regards to the outlook for ONE HEALTH. We've already demonstrated strong organic growth, and that's continued post COVID indeed. We were providing that growth pre COVID. The independent sector is helping support the NHS in achieving its targeted decrease in its waiting list. And this has been supported by the current prime minister who is who's who's due not to be current and also the previous health secretary.
25:37 But again, present health secretary is is is part of it. And the use of the independent sector to help with waiting list is part of the ten year plan. Now we don't know which which burn and we're going to get coming in soon, but we're confident that they will continue to use the independent the independent sector in helping deliver the NHS care. So activity has remained strong. All our key performance indicators are positive. We're moving forward. We have lots of patients. We have lots of surgeons who want to work with us. And as you'll see, you can also see how we now have a second arm to our growth with this strategic growth with the surgical hubs. So we're confident. Just to explain again about the significant market opportunity, the government within the four specialties that we operate in, orthopedics, spines, general, and gynecology, the government spends 13,400,000,000 per year on providing that service.
26:33 The independent sector only provides 11% and that is increasing. ONE HEALTH only provides naught point 2%. So there's a huge opportunity for growth within this sector. So we have, you know, very strong ambitions for ONE HEALTH. This isn't a forecast at all, but based on our organic growth and our strategic growth of opening a hub a year, we're looking in the medium term to be an 80,000,000 turnover company and in the longer term to be a 200,000,000 turnover company. So we think we've demonstrated the growth. We're confident, and we're confident for the future for ONE HEALTH. Okay. Thank you for listening. That ends the formal presentation, so we will turn to questions now. That's great. Thank you very much for your presentation this afternoon. If I may just bring back up your cameras. Ladies and gentlemen, please do continue to submit your questions just by using the q and a tab situated on the right hand corner of your screen. Just while the company take a few moments to review those questions submitted today, I'd like to remind you that recording of this presentation along with a copy of the slides and the published q and a can be accessed via investor dashboard.
27:38 As you can see, we have just received a number of questions throughout today's presentation. Alice, if I could just hand back to you, just read out the questions to share with the team, and I'll pick up from you at the end. Fantastic. Thanks, Lily. The first question was actually on ONE Health strategy in regards to potential changes with government policy, but we've kind of already discussed that. And second question is, in terms of the surgical hub strategy, how does the company plan to fund future surgical hubs? Will the rollout of other hubs be implemented after the first hub is fully operational? Okay. I'll be on with that. Yeah. So I think we've demonstrated in the slide pack just we've just run through now that we do generate a lot of cash. I think we showed that there was growth sort of free cash within 2026, around 2,500,000. The other key point in terms of future growth is our change of banks quite recently.
28:27 We moved to Barclays. Barclays are the biggest fund of health care in The UK and are very keen to support ONE HEALTH GROUP. So cash generation internally is a strong feeder of future growth. Bank debt through a combination of funding of the existing site we're building at the moment, they're keen to put some debt against that. We've also got a head office in Sheffield worth around 2,700,000. There's a million pound loan against that. There's another £1,200,000 there. So if we effectively fund the or get debt against the land already bought at Scunthorpe and part of that hub plus the head office in Sheffield plus cash generation, we're very quickly at seven to eight million pounds. Surgical hubs cost between 8 and 9, so we're very comfortable. We'd probably self fund the first one without the need for more equity.
29:12 Now clearly, once we prove the concept, we'd like to accelerate growth. There's no reason we can't do one or two at the same time. And certainly, in line with our strategy to build one a year, we may come back for equity, but that's not the intention at this stage. We'd like to prove the concept, use cash generated and bank debt to get into number two quite quickly. And as I mentioned previously, we've already looked at two of the sites in South Derbyshire and West Yorkshire, which will probably be the next piece of land we acquire for building on. Excellent. Thank you, Adam. The next question is how dependent is the company's growth on NHS waiting list pressures? Again, if you go back to the presentation, I think it's worth highlighting. It's a strong point that of 95% of our activity last year to 2026 was GP referrals. I'll stress these are brand new patients, go to the GP, refer to ONE HEALTH GROUP, treat them discharged.
30:01 So just that waiting list, the 7,100,000 at the end of March we talked about, we're not really touching that just yet. The only time we see that is generally towards the end of the year around quarter four. We get calls from local trusts asking for support with reducing our internal waiting list, which is where the waiting list sits across England. It's in inside NHS trusts. So 5% of our revenue last year in patient numbers was transfers in quarter four from NHS trusts, which is a tiny, tiny fraction, that 7,100,000 that needs to come down to meet the government's targets. You may have seen in the press that the aspiration from the government is to achieve the old, target of ninety five percent of patients treated with eighteen weeks by March 29. Now in real terms, that means reducing that 7.1 waiting list to around three million in the next three years, which is a monumental task.
30:48 And, certainly, it's been demonstrated already that the independent sector's contribution to support the NHS has grown significantly. Pre dump pre pandemic, around six or 7% of outsourced activity. It peaked at 13% last year. So I think it demonstrates clearly that without support, that weight isn't gonna come down by any significance, and we do it at the same price. Bear in mind, we get paid the same with NHS trusts. There's no premium to that. So it makes a lot of sense to outsource the more straightforward activity, hips and knees and the likes, out to the inter independent sector and focus on the complicated stuff and really drive down that waiting list. So we are confident that waiting list will be a future part of our business, but to stress the organic growth we've demonstrated is not touching that waiting list yet. If I could just make a a further observation, I mean, HEALTH was born in 2004 in the last labor government where they they wanted to get waiting list down. And so at one point in ONE HEALTH history, waiting list were down to about 1,800,000.
31:44 And we had to strive a strong and growing business at that time. Waiting list are ridiculously high now. The the independent sector has been embedded in getting waiting list down now for about the last thirty years. So we will so the the use of the independent sector will be fundamental in getting these waiting list down, but they will still be needed to maintain the waiting list of those areas. So it's not so much waiting list pressures or once they're down to their desired target, the independent sector aren't involved. To get to that desired target, the what the independent sector has to do more and more and more of a percentage of that work. And so they'll need they will need the independent sector to maintain it there. So we're very, very confident that the the model that we have built in will be built in to the NHS provision for for elective elective operating.
32:34 And following on from that question, how secure are your contracts with the NHS? That's an easy one to answer. We've never ever lost a contract in twenty two years. So mentioned on the geographic coverage slide, the the way we we grow organically is through building on the periphery through outreach clinics and then finding independent hospitals support the surgical work required. And the way that works is we become more and more, well, prevalent in areas where we haven't been before through noncontract activity growth. And then the ICVs get to say, can we contract with you formally? So it moves noncontract to contract. The difference is academic in real terms because noncontract is effectively contracted work. We still get paid. So the contracts keep on growing, and we've never lost one yet. And I mentioned previously, we've got more now on long term contracts. We secured two five year contracts two years ago. We've added two more this year onto the balance of those five years. So 80% of our work is now on long term contracts, which is a fundamental shift from five years ago.
33:30 Next question. I've heard people describe you as a mini Spire. Could you explain how you differ from them? Yeah. That's pretty straightforward, really. I mean, the the basic business model is completely different. Spire is a very successful independent sector company that runs a hospital centric model for private medical insurance and self pay work principally. It will do some NHS work, but the core model is to do NHS to do the the the private work. And as I say, it does it through a hospital centric model, not a community centric model. So our business model is completely different. We provide a community centric model for NHS patients, and as we've described earlier, we think we will always be required to help the NHS maintain their low waiting lists.
34:26 So the only similarity between us and ONE HEALTH, I mean, I wish we were a billion revenue company, but apart from that, maybe one day. But but ours is fundamentally different. And we think ours is a more robust business model to be able to provide a service to the NHS in the future moving forward. And in addition, we're also buffered again to say there were any changes in how elective care is managed. And our view really is that in the future, elective care will probably go more towards European system where the social insurance. But to be able to provide that, you really need a low cost solution to do that. And we provide a low cost solution with community care, not a hospital centric model, which is a very hungry beast needing more and more patients to do more and more diagnostics, rehabilitation, consultations operating, whereas we've devolved that out into the out into the community.
35:22 So ours is a distinctly different model to that offered by Spire or indeed any of the other big independent sector hospital groups such as Circle, Nuffield, or or Ramsey. Excellent. Thanks, Derek. The next question is from John. With 80% of revenue from inpatient and surgical activity, how is the revenue mix likely to evolve as consultations outpace procedures? Okay. Good question. So to put it in perspective, does it revenue first of all? So a consultation, bear in mind, we're paid on the NHS tariff, get paid as the same as the trust, as I mentioned. We do currently five different specialties. The range of fees we receive for initial consultation are between 300 and £450, so quite a low proportion of our total turnover.
36:08 Typical procedure, looking at the biggest stuff like orthopedics and spines, 5 to £6,000 is is kind of the the lower end of where where those speech can cost. So I'd imagine the revenue split will always be biased heavily towards inpatient eighty percent. That said, we're we're doing more specialties now than we used to do. We're doing urology now, which is obviously a different mix in terms of referral to surgery, but we've always seen in the region of forty percent of new to inpatient conversions. Certainly, the time I've been with ONE HEALTH, it's between one or two percent of the forty percent measure. So I can't see a massive change in that. And if we do start seeing more consultations and less referrals for inpatient, we'll just open the door to more new patients to make sure we maintain that revenue stream. So there's no risk around that. But the con conversation around consultation versus inpatient been fairly constant for the past eight to nine years I've been around.
37:00 Next question. How much margin presently ceded to independent hospitals will be captured by the surgical hubs when they're opened? Okay. So very, simple terms. We've managed to grow our internal gross margin percent over the past three years to 20.2% last year. That's a significant increase. Some of that is tariff increases. You may have seen in the press that when industrial disputes are settled with consultants, resident doctors, junior doctors previously, what happens when they are settled is the tariff is increasing. We don't bear the cost of those cost increases because our costs are fairly static, but we bear the benefit of the tariff increases. So we get a disproportional margin uplift because of that. We also work really hard on driving our cost of sales, maximizing efficiency, increase that gross margin. So in terms of the split between what independent hospitals get today versus the future with a surgical hub, very, very approximate 10 to 12% differential.
37:51 So any work and there should be new work in hubs, not moving work into. There's no point in doing that. That's not growth. Any work, new surgeons, or new activity brought into the hubs will gain 10 to 12% of the gross margin terms. So 20 to 30 to 32 is the is the answer to the question simplistically. Thank you. Do you see much turnover in consultant surgeons and orthopaedic gynaecologists apart from retirement? The answer is no. We have no problem recruiting surgeons. As I explained earlier, like the product that we have, They like working for us. We do get when people retire. I mean, started ONE HEALTH twenty two years ago. I mean, I worked in ONE HEALTH up until recently. I retired two years ago.
38:36 The original six surgeons we started with have either retired or or are just retiring. And that's a natural, a natural process. What would tend to be recruiting are the younger surgeons coming through to replace them. They then join us because they want to build their private practice. They can't because there's not enough self paying private medical insurance, so they join ONE HEALTH. So we see a constant evolution. We're we're very picky on who joins ONE HEALTH. We have a strict onboarding process, so we only get people who we really want, people who buy into the ethos of ONE HEALTH, which is more patient focused, community centric. So we have very low, turnover of surgeons. Those who join us tend to stay with us, but the numbers who leave are are are are minimal.
39:21 And just to support that, if you I've mentioned on previous slide, we've got 22 of those subcontracting consultants that are shareholders in the group. Of those 22, I think 17 have been with us for over fifteen years. So a strong indication for not only loads to the business demonstrated by buying equity, but also the financial benefit it gives them for working for us. It's it's a very effective, very efficient, attractive model for them. And they often act as our ambassadors. I gave an example in a previous conversation. When these guys go out and do their NHS work and go to conferences on behalf of the NHS, they'll talk about the benefits of ONE HEALTH GROUP. We often get calls on the back of their meetings and their their conferences. Thank you. And how does the price that you're reimbursed for an operation compared to the internal cost in a hospital?
40:08 Very simple answer. So if you look at EBITDA for ONE HEALTH GROUP for 2026, we clear about seven percent on revenue. Look at the typical deficit for a trust. They operate at a 4% deficit. So in cost terms, the differential is about 11% on paper. We're efficient. At the moment, the NHS is not as efficient as it should be, so it spends more than it receives. Excellent. Thank you. Can urology become a big earner for you? I I doubt whether it would be a big earner for us because it's it tends to be more outpatient relatively apart from cancer work. Most of urology is is dealt with in an outpatient basis often with in fact, in in training now, you can be a a a office based urologist and not a surgeon at all. And there's lots of nurse led investigations and treatment done with it. So it's good for us in that we already have our outpatient network.
41:04 And so it's relatively easy to plug that in. There's not a lot of capital cost for for instruments that we might need to use in an outpatient area. But because it's outpatient based, the outpatient tariff is relatively low, so the margins are relatively low for that. So it's relatively straightforward for us to to do that, and it will grow, but I don't think it'll be a major growth. As I said earlier, so, you know, 80%, 13,400,000,000 accounts for 80% of those people on the waiting list. So we're already doing the big beast if you like. But we will look at other opportunities such as, for instance, ENT or surgical aspects of dermatology. So there are some things that we can look at, but but none with major major revenue implications.
41:51 And then just one final question. I was under the impression that you were looking to open a hub near Harrogate. Is that still the case? Or No. Harrogate's certainly not a target region. It's quite an affluent area, Harrogate. I'm sure you may have been there, John, if you've been around a while. We do use a Circle Hospital in Harragut in terms of one of our facilities, but the target regions at the moment and I'm looking at sites last week, funny enough, are West Yorkshire. Bradford area is particularly attractive for us, and South Derbyshire. We had a board meeting on Friday, and we're probably gonna progress negotiations on one of those two sites quite quickly. It's a very attractive site, but certainly Harrogate's not doesn't meet the criteria of lack of affluence and lack of built self pay. There are plenty of wealthy people up there who were able to pay or have private medical insurance. So not a target area for OHGR, definitely not. And also wherever we open these hubs, you know, we are we partner with the independent sector. What we will not do is open a surgical hub on the doorstep of one of these major groups. And as you know, within Circle, there's a very successful hospital in Harrogate. So that's an example of a type of area we wouldn't do.
42:55 Rather than there, we would probably go over into North Lancashire, Cumbria, or maybe up into the Northumberland area, South the Teaside area. Not really. Or the coast, to be honest, the the North Yorkshire Coast rather than an area like like Harrogate. And then one final question from John. What sort of general surgery do you do? Is it all kind of hernias and gallbladders? Yeah. It's it's basically what we don't do is we don't do cancer surgery because that needs a completely different needs a more of an MDT approach with two week waitings. We're we're not contracted for that. We were never asked to provide that. So if you take out cancer, we provide everything else. So gallbladders, hernias, etcetera, etcetera, those those types of those types of procedures.
43:40 Excellent. Thank you. That concludes the questions. So I'll hand back to Lily. That's great. Thank you for answering those questions you care from investors. And, of course, the company can review all questions submitted today, and we'll publish those responses on the investor meet company platform. Just before redirecting investors to provide you their feedback, which are particularly important to the company, Derek, could I please just ask you for a few closing comments? Yeah. Thank you, Lily. Thank you. Well, I hope you enjoyed the presentation. I hope we got across to you the type of company that we are. You know, we're a very ambitious company. We've we've taken a lot of time and a lot of effort to set us up from a regulatory point of view. So we're very, reliable, company. We've demonstrated good growth we've also demonstrated to you how we're gonna gonna grow further. And also, we're a company that provides a social social good. We provide social good. And what we're doing is in line with what this government or any future government would do. So it's, you know, it's always great to get up in the morning and and work in a company that is doing such good, basically getting people off waiting list back to good health and back out into the community.
44:49 That's great. Thank you for updating investors today. Can I please ask investors not to close the session as you'll now be automatically redirected to provide your feedback in order that the management team can better understand your views and expectations? This may only take a few moments to complete, and I'm sure be greatly valued by the company. On behalf of the management team, we'd like to thank you for attending today's presentation, and good afternoon to you all. Thank you. Thank you.
Follow One Health Group PLC into a list and get an email when it puts out news.
Chairman at ONE HEALTH GROUP PLC
CEO at ONE HEALTH GROUP PLC